Abu Dhabi unveils CASGEVY treatment for sickle Cell and Thalassemia | Healthcare Asia Magazine
, Middle East
Photo from Envato

Abu Dhabi unveils CASGEVY treatment for sickle Cell and Thalassemia

The first patient is scheduled to begin therapy at Yas Clinic Hospital in April.

The Department of Health – Abu Dhabi (DoH) has announced the launch of CASGEVY, a CRISPR/Cas9 gene-editing therapy aimed at treating sickle cell disease and transfusion-dependent beta-thalassemia

The treatment is provided by Abu Dhabi Stem Cells Center, with the first patient scheduled to begin therapy at Yas Clinic Hospital in April.

The therapy extracts stem cells from a patient’s bone marrow, genetically edits them, and reimplants them into the body, according to the DoH.

 

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!